All Stories
Follow
Subscribe to AGENNIX AG i.L.

AGENNIX AG i.L.

EANS-Voting Rights: AGENNIX AG
Release according to article 26, section 1 WpHG (Securities Trading Act) with the aim of Europe-wide distribution

--------------------------------------------------------------------------------
  Notification of voting rights transmitted by euro adhoc. The issuer is
  responsible for the content of this announcement.
--------------------------------------------------------------------------------
Announcement according to Article 21, Section 1 of the WpHG (share)
Koninklijke DSM N.V., Heerlen, The Netherlands
Gist-Brocades International B.V., Delft, The Netherlands
On October 27, 2010, Koninklijke DSM N.V., Heerlen, The Netherlands, informed us
pursuant to Sec. 21 para 1 WpHG that they have not taken part in the recent
increase of the statutory capital of Agennix AG by which Agennix AG issued
20,588,705 new shares. As a result, their percentage of voting rights in Agennix
AG (represented by 915,538 shares held by their fully controlled subsidiary
Gist-Brocades International B.V. and attributed to Koninklijke DSM N.V. pursuant
to Sec. 22 para 1 no. 1 WpHG) have fallen below 3% on October 4, 2010 and are as
per this date only 2.21% of the total voting rights in Agennix AG.
On October 27, 2010, Gist-Brocades International B.V., Delft, The Netherlands,
informed us pursuant to Sec. 21 para 1 WpHG that they have not taken part in the
recent increase of the statutory capital of Agennix AG by which Agennix AG
issued 20,588,705 new shares. As a result, their voting rights in Agennix AG
(represented by 915,538 shares) have fallen below 3% on October 4, 2010 and are
as per this date only 2.21% of the total voting rights in Agennix AG.
Heidelberg, October 28, 2010
Agennix AG
The Management Board (Vorstand)
end of announcement                               euro adhoc
--------------------------------------------------------------------------------

Further inquiry note:

Investor Relations & Corporate Communications
Tel.: +49 (0) 89 8565 2693
E-Mail: ir@agennix.com


Branche: Pharmaceuticals
ISIN: DE000A1A6XX4
WKN: A1A6XX
Index: CDAX, Prime All Share, Technology All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade

Original content of: AGENNIX AG i.L., transmitted by news aktuell

More stories: AGENNIX AG i.L.
More stories: AGENNIX AG i.L.